APLCC ORAL ABSTRACT SESSIONS - MONDAY, NOVEMBER 26

Slides:



Advertisements
Similar presentations
A Prognostic Scoring Model for the Utility of Induction Chemotherapy Prior to Neoadjuvant Chemoradiotherapy in Esophageal Cancer  Mian Xi, MD, Zhongxing.
Advertisements

Frances A Shepherd, MD, Rafael Rosell, MD  Journal of Thoracic Oncology 
A2-06: Survival differences for non-Bronchioloalveolar Carcinoma (BAC) non-small-cell lung cancer (NSCLC) cases with ipsilateral intrapulmonary metastasis.
High Discrepancy of Driver Mutations in Patients with NSCLC and Synchronous Multiple Lung Ground-Glass Nodules  Chunyan Wu, MD, Chao Zhao, MD, Yang Yang,
Primary Signet-Ring Carcinoma (SRC) of the Lung: A Population-Based Epidemiologic Study of 262 Cases with Comparison to Adenocarcinoma of the Lung  Sai-Hong.
PUBLISH ONLY Journal of Thoracic Oncology
Perioperative versus Preoperative Chemotherapy with Surgery in Patients with Resectable Squamous Cell Carcinoma of Esophagus  Yang Zhao, MD, ZhiJun Dai,
Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer  Sai-Hong Ignatius Ou, MD, PhD, Jason.
SC17.02 Lung Cancer in China: Challenges and Perspectives
Prognostic Significance of TAZ Expression in Resected Non-Small Cell Lung Cancer  Mian Xie, MD, PhD, Li Zhang, MD, Chao-Sheng He, MD, Jin-Hui Hou, MD,
Results of Surgical Treatment for Patients with Small Cell Lung Cancer
Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 
Significance of Programmed Cell Death-Ligand 1 Expression and its Association with Survival in Patients with Small Cell Lung Cancer  Hidenobu Ishii, MD,
Ellen M. Schultz, MS, Gerard A. Silvestri, MD, MS, Michael K
Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer  Hong.
NA  Journal of Thoracic Oncology 
Electronic Updates for JTO Readers
IA05.01 Lung Cancer Cases Journal of Thoracic Oncology
Central versus Peripheral Tumor Location: Influence on Survival, Local Control, and Toxicity Following Stereotactic Body Radiotherapy for Primary Non–Small-Cell.
Phase II Trial of Paclitaxel and Cisplatin in Patients with Extensive Stage Small Cell Lung Cancer: Cancer and Leukemia Group B Trial 9430  Thomas E.
The Influence of the Evolution of First-Line Chemotherapy on Steadily Improving Survival in Advanced Non-Small-Cell Lung Cancer Clinical Trials  Krista.
Patterns of survival and recurrence after surgical treatment of early stage non–small cell lung carcinoma in the ACOSOG Z0030 (ALLIANCE) trial  Stacey.
Detection of Lung Cancer by Automated Sputum Cytometry
Prognostic Factors in Patients with Pathologic T1-2N1M0 Disease in Non-small Cell Carcinoma of the Lung  Katsunari Matsuoka, MD, Shinichi Sumitomo, MD,
Meta-Analysis of First-Line Therapies in Advanced Non–Small-Cell Lung Cancer Harboring EGFR-Activating Mutations  Benjamin Haaland, PhD, Pui San Tan,
Lung Cancer and Prognosis in Taiwan: A Population-Based Cancer Registry  Bing-Yen Wang, MD, Jing-Yang Huang, Ching-Yuan Cheng, MD, Ching-Hsiung Lin, MD,
Clinical Characteristics and Outcomes for Patients With Thymic Carcinoma: Evaluation of Masaoka Staging  Anya M. Litvak, MD, Kaitlin Woo, MS, Sara Hayes,
Jeffrey Bradley, MD, Issam El Naqa, PhD  Journal of Thoracic Oncology 
Impact of Positive Nodal Metastases in Patients with Thymic Carcinoma and Thymic Neuroendocrine Tumors  Benny Weksler, MD, Anthony Holden, MD, Jennifer.
Effects of Chemotherapy on Survival of Elderly Patients with Small-Cell Lung Cancer: Analysis of the SEER-Medicare Database  Laura C. Caprario, MD, MS,
Erik Jakobsen, Maria Iachina, Karen Ege Olsen, Anders Green 
Socioeconomic Status Is Associated with Depressive Severity Among Patients with Advanced Non–Small-Cell Lung Cancer: Treatment Setting and Minority Status.
PUBLISH ONLY Journal of Thoracic Oncology
Re-evaluation of the Role of Postoperative Radiotherapy and the Impact of Radiation Dose for Non–Small-Cell Lung Cancer Using the National Cancer Database 
PD-L1 as a Companion Biomarker for Immune Checkpoint Inhibitors in NSCLC: Should RNA ISH (RISH) Be Considered?  Steven G. Gray, PhD  Journal of Thoracic.
Daniel Morgensztern, MD, Boone Goodgame, MD, Maria Q
Re-evaluating the Optimal Radiation Dose for Definitive Chemoradiotherapy for Esophageal Squamous Cell Carcinoma  Liru He, MD, Pamela K. Allen, PhD, Adam.
Erratum Journal of Thoracic Oncology
PUB010 Intraoperative Blood Loss is an Independent Predictor of Poor Disease Free Survival for Patients Undergoing VATS Lobectomy for Lung Cancer  M.
Elizabeth Cathcart-Rake, MD, Ariel Lopez-Chavez, MD, MS 
Heidi B. Rolke, Frode Gallefoss  Journal of Thoracic Oncology 
Mitotic Inhibitors Journal of Thoracic Oncology
P3-255: Tumor size as a prognostic factor for the survival of surgically treated stage Ia non-small cell carcinoma  Gustavo A. Lyons, Silvia Quadrelli,
Impact of Non–Small-Cell Lung Cancer-Not Otherwise Specified Immunophenotyping on Treatment Outcome  Luisella Righi, MD, PhD, Tiziana Vavalà, MD, Ida.
Mirror Mirror on the Wall, Who Is the Fairest of Them All
ES Lung Cancer Surgery for High Risk Patients
MTP13-01: Indications and limitations of bronchoscopy
Trends in Stage Distribution for Patients with Non-small Cell Lung Cancer: A National Cancer Database Survey  Daniel Morgensztern, MD, Shean Huey Ng,
Peripheral Direct Adjacent Lobe Invasion Non-small Cell Lung Cancer Has a Similar Survival to That of Parietal Pleural Invasion T3 Disease  Hao-Xian Yang,
The Prognostic Impact of Cigarette Smoking on Patients with Non-small Cell Lung Cancer  Ryo Maeda, MD, Junji Yoshida, MD, PhD, Genichiro Ishii, MD, PhD,
Gemcitabine in Brief versus Prolonged Low-Dose Infusion, both Combined with Cisplatin, for Advanced Non-small Cell Lung Cancer: A Randomized Phase II.
Conditional Survival of Malignant Thymoma Using National Population-Based Surveillance, Epidemiology, and End Results (SEER) Registry (1973–2011)  Ellen.
Should Large Cell Neuroendocrine Lung Carcinoma be Classified and Treated as a Small Cell Lung Cancer or with Other Large Cell Carcinomas?  John M. Varlotto,
A2-06: Survival differences for non-Bronchioloalveolar Carcinoma (BAC) non-small-cell lung cancer (NSCLC) cases with ipsilateral intrapulmonary metastasis.
A Prognostic Scoring Model for the Utility of Induction Chemotherapy Prior to Neoadjuvant Chemoradiotherapy in Esophageal Cancer  Mian Xi, MD, Zhongxing.
Maintenance Therapy and Advanced Non–Small-Cell Lung Cancer: A Skeptic's View  Martin J. Edelman, MD, Thierry Le Chevalier, MD, Jean-Charles Soria, MD,
Prognosis of Resected Non-Small Cell Lung Cancer Patients with Intrapulmonary Metastases  Kanji Nagai, MD, Yasunori Sohara, MD, Ryosuke Tsuchiya, MD,
Bolstering the Case for Lobectomy in Stages I, II, and IIIA Small-Cell Lung Cancer Using the National Cancer Data Base  Susan E. Combs, MA, Jacquelyn.
A Dose Finding Study of Weekly and Every-3-Week nab-Paclitaxel Followed by Carboplatin as First-Line Therapy in Patients with Advanced Non-small Cell.
MTP19-01: T4 N0/N1 nonsmall cell lung cancer can be cured as a first line treatment with an expected five year survival rate as high as 43% provided a.
International Thymic Malignancies Interest Group: A Way Forward
European Lung Cancer Conference (ELCC) 2016 Organisation
PD6-3-6: A phase 3 randomized, double blind, placebo-controlled study of patients with previously untreated extensive-stage small cell lung cancer (SCLC)
PS01.07 The Clinical Necessity of Extended Thymectomy for Thymic Squamous Cell Carcinomas Revealed by Exome Sequencing  J. Jiang, Y. Zhang, C. Jin, J.
IASLC 6th Latin American Conference on Lung Cancer
OA Survival Trends Among Non-Small Cell Lung Cancer (NSCLC) Patients Over A Decade: Impact of Initial Therapy at Academic Centers  B. Dholaria,
APLCC POSTER SESSION 2 - WEDNESDAY, NOVEMBER 28
Surveillance Epidemiology and End Results Evaluation of the Role of Surgery for Stage I Small Cell Lung Cancer  James B. Yu, MD, Roy H. Decker, MD, PhD,
A Review of First-Line Treatment for Small-cell Lung Cancer
Mark A. Socinski, MD  Journal of Thoracic Oncology 
Presentation transcript:

APLCC ORAL ABSTRACT SESSIONS - MONDAY, NOVEMBER 26   Journal of Thoracic Oncology  Volume 7, Issue 11, Pages S447-S452 (November 2012) DOI: 10.1097/01.JTO.0000423885.91281.a3 Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

Figure 1 Overall survival curves of 738 NSCLC patients who were performed VATS lobectomy. Journal of Thoracic Oncology 2012 7, S447-S452DOI: (10.1097/01.JTO.0000423885.91281.a3) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

Figure 2 Disease free survival curves of 738 NSCLC patients who were performed VATS lobectomy. Journal of Thoracic Oncology 2012 7, S447-S452DOI: (10.1097/01.JTO.0000423885.91281.a3) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2012 7, S447-S452DOI: (10. 1097/01. JTO Journal of Thoracic Oncology 2012 7, S447-S452DOI: (10.1097/01.JTO.0000423885.91281.a3) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2012 7, S447-S452DOI: (10. 1097/01. JTO Journal of Thoracic Oncology 2012 7, S447-S452DOI: (10.1097/01.JTO.0000423885.91281.a3) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2012 7, S447-S452DOI: (10. 1097/01. JTO Journal of Thoracic Oncology 2012 7, S447-S452DOI: (10.1097/01.JTO.0000423885.91281.a3) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

Fig The survival curves of adenocarcinoma, peripheral squamous cell carcinoma and various subtypes of adenocarcinoma between VI positive (red line) and negative cases (green line). Journal of Thoracic Oncology 2012 7, S447-S452DOI: (10.1097/01.JTO.0000423885.91281.a3) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2012 7, S447-S452DOI: (10. 1097/01. JTO Journal of Thoracic Oncology 2012 7, S447-S452DOI: (10.1097/01.JTO.0000423885.91281.a3) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

Journal of Thoracic Oncology 2012 7, S447-S452DOI: (10. 1097/01. JTO Journal of Thoracic Oncology 2012 7, S447-S452DOI: (10.1097/01.JTO.0000423885.91281.a3) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.